586 related articles for article (PubMed ID: 6591204)
1. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
2. Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E.
Hui DY; Innerarity TL; Mahley RW
J Biol Chem; 1984 Jan; 259(2):860-9. PubMed ID: 6319389
[TBL] [Abstract][Full Text] [Related]
3. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
4. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
[TBL] [Abstract][Full Text] [Related]
6. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Sandholzer C; Feussner G; Brunzell J; Utermann G
J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
[TBL] [Abstract][Full Text] [Related]
7. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
8. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Evans AJ; Wolfe BM; Strong WL; Huff MW
Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
Huff MW; Breckenridge WC; Strong WL; Wolfe BM
Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
[TBL] [Abstract][Full Text] [Related]
10. Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro.
Eisenberg S; Patsch JR; Sparrow JT; Gotto AM; Olivecrona T
J Biol Chem; 1979 Dec; 254(24):12603-8. PubMed ID: 227902
[TBL] [Abstract][Full Text] [Related]
11. Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T; Shepherd J; Packard CJ
Klin Wochenschr; 1988 Aug; 66(16):703-12. PubMed ID: 3050267
[TBL] [Abstract][Full Text] [Related]
12. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
[TBL] [Abstract][Full Text] [Related]
13. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
Nestel P; Billington T
Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
[TBL] [Abstract][Full Text] [Related]
14. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
[TBL] [Abstract][Full Text] [Related]
15. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
Kissebah AH; Alfarsi S; Adams PW
Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
[TBL] [Abstract][Full Text] [Related]
16. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
18. Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1988 Aug; 82(2):628-39. PubMed ID: 2841358
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis.
Huang Y; Schwendner SW; Rall SC; Sanan DA; Mahley RW
J Biol Chem; 1997 Sep; 272(36):22685-94. PubMed ID: 9312550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
